ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2017
Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.
Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 21 citations in OpenAlex.
- Association of Left Atrial Function With Incident Chronic Kidney Disease in Older Adults.Mayo Clinic proceedings. Innovations, quality & outcomes · 2024Article
- Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney Disease.Medicina (Kaunas, Lithuania) · 2024Article
- Multimorbidity in African ancestry populations: a scoping review.BMJ global health · 2023Article
- Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023Observational
- Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study.BMC cardiovascular disorders · 2022Article
- Echocardiographic measures and subsequent decline in kidney function in older adults: the Atherosclerosis Risk in Communities Study.European heart journal. Cardiovascular Imaging · 2022Article
- Renal dysfunction in cardiovascular diseases and its consequences.Journal of nephrology · 2021Review
- Perceived Discrimination and Trajectories of C-Reactive Protein: The Jackson Heart Study.American journal of preventive medicine · 2020Article
- Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.Heart failure reviews · 2019Review
- Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD.BMC nephrology · 2018Article
- Kidney Appreciates Stable Blood Pressure.American journal of hypertension · 2018Article
- Albuminuria and kidney function as prognostic marker of left ventricular mass among South Asians with hypertension.Journal of the American Society of Hypertension : JASH · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundCardiac structural abnormalities, common in African Americans, are associated with adverse clinical outcomes. Associations between echocardiography-measured subclinical heart failure and kidney function decline are unknown and may identify novel risk factors for kidney disease in this population. STUDY
designProspective cohort study. SETTING &
participants2,418 Jackson Heart Study participants with baseline echocardiograms and longitudinal measures of estimated glomerular filtration rate (eGFR) calculated from the CKD-EPI creatinine equation. 2,219 participants had baseline eGFRs≥60mL/min/1.73m PREDICTORS: Left ventricular mass (LVM) and ejection fraction (LVEF) and pulmonary artery systolic pressure (PASP) quantified from baseline echocardiograms. OUTCOMES: Primary outcome was >30% eGFR decline or progression to end-stage renal disease (ESRD; need for dialysis therapy) over a mean of 8 years. Secondary outcome, eGFR<60mL/min/1.73m MEASUREMENTS: Logistic regression models, adjusted for demographics, physical characteristics, comorbid conditions, and medication use.
resultsMean age was 52.2±11.9 (SD) years, 37% of participants were men; mean baseline eGFR was 87.3±17.3mL/min/1.73m LIMITATIONS: No midstudy creatinine measurement at examination 2.
conclusionsGreater LVM was significantly associated with eGFR decline > 30% or ESRD among African Americans in a community-based cohort. Treating and reversing elevated LVM may reduce the burden and progression of kidney disease in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.